Tri-Methyl-Histone H4 (Lys79) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Phosphate Buffered Saline (PBS), pH 7.4, containing 0.02% sodium azide as a preservative and 50% glycerol.
Form
Liquid
Lead Time
Typically, we are able to dispatch the products within 1-3 business days after receiving your order. Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery time details.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome, which plays a crucial role in packaging and compacting DNA into chromatin. This compaction limits DNA accessibility to cellular machinery that requires DNA as a template. Consequently, histones play a pivotal role in regulating transcription, DNA repair, DNA replication, and maintaining chromosomal stability. The accessibility of DNA is regulated through a complex interplay of post-translational modifications of histones, also known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Research indicates that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Studies suggest that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break, and the process requires the participation of SETD2, LEDGF, and KAT5 (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5). PMID: 28546430
  3. Data show that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus seems to be linked to an imbalance between histone acetyltransferases and histone deacetylase enzymes, favoring pathologic H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during the reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines corresponds to increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that histone assembly during the G1 phase is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers are major nuclear proteins whose binding of the histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to the epigenetic mechanism by suppression of acetylation of histone H4. PMID: 21973049
  13. Our findings suggest that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47 catalyzed by the PAK2 kinase promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4. PMID: 20949922
  17. Our findings reveal the molecular mechanisms whereby the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which, in turn, reduces gene expression by half. PMID: 20512922
  18. Histone H4 is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alterations in gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation level of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. The incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. There is a relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for the extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation have novel roles in mediating the recruitment of multiple regulatory factors that can change chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are important for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Our findings indicate an important role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate that, by acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation, within genes when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is Tri-Methyl-Histone H3 (Lys79) and why is it significant in epigenetic research?

Tri-Methyl-Histone H3 (Lys79) refers to histone H3 protein that has been tri-methylated at lysine 79. This modification is unique as it occurs within the globular domain of histone H3 rather than on the N-terminal tail where most histone modifications are found.

H3K79 methylation is significant because:

  • It plays a crucial role in transcriptional regulation

  • It functions in DNA repair mechanisms, particularly nucleotide excision repair (NER)

  • It contributes to heterochromatin formation and silencing

  • It affects chromatin structure and accessibility

Studies have shown that H3K79 methylation is mediated by the DOT1/DOT1L methyltransferase and has been implicated in both transcriptional activation and silencing . Unlike many histone modifications that occur on the histone tails, H3K79 is located in the nucleosome core, making it structurally distinct and functionally specialized.

What experimental applications are suitable for Tri-Methyl-Histone H3 (Lys79) antibodies?

Tri-Methyl-Histone H3 (Lys79) antibodies can be utilized in multiple experimental techniques:

ApplicationRecommended DilutionNotes
Western Blotting (WB)1:1000Detects a band at approximately 17 kDa
Chromatin Immunoprecipitation (ChIP)1:50Effective for mapping genome-wide distribution
ChIP-seq1:50For next-generation sequencing applications
Immunofluorescence (IF)Varies by antibodyFor visualizing nuclear distribution patterns
Dot BlotVaries by antibodyFor quick screening of samples

For optimal results, validation in each specific application is recommended, as antibody performance may vary depending on experimental conditions and sample preparation methods.

How do I verify the specificity of Tri-Methyl-Histone H3 (Lys79) antibodies?

Verifying antibody specificity is critical for ensuring reliable results. Recommended validation approaches include:

  • Peptide Array Analysis: This quantitative approach can determine specificity factors for different methylation states (mono-, di-, and tri-methylation) of the target lysine residue. Specificity factors represent the ratio of average signal intensity for spots containing the target modification versus spots lacking that modification .

  • Competitive ELISA: Test antibody binding against the target peptide (H3K79me3) versus peptides with related modifications (H3K79me1, H3K79me2, or unmodified H3K79) .

  • Western Blot Controls: Use samples from:

    • Wildtype cells

    • DOT1/DOT1L knockout or knockdown cells (which should show decreased H3K79me3 signal)

    • H3K79R mutant cells (which cannot be methylated at this position)

  • Peptide Competition Assays: Pre-incubating the antibody with excess H3K79me3 peptide should abolish specific signals in your application.

The most rigorous validation combines multiple approaches to confirm that the antibody specifically recognizes H3K79me3 without cross-reactivity to other histone modifications.

What role does H3K79 methylation play in DNA repair mechanisms?

H3K79 methylation significantly impacts DNA repair, particularly nucleotide excision repair (NER). Research has demonstrated that:

  • UV Sensitivity: H3K79R methylation mutants (which cannot be methylated at lysine 79) show increased sensitivity to UV irradiation compared to wildtype cells, indicating a protective role for H3K79 methylation against UV-induced DNA damage .

  • Repair Efficiency: H3K79 methylation is required for efficient nucleotide excision repair. Studies have shown that H3K79R mutants have decreased capacity to repair UV-induced DNA lesions, particularly in silenced chromatin regions .

  • Chromatin Accessibility: H3K79 methylation affects chromatin structure and accessibility to repair factors. MNase digestion experiments revealed that H3K79R mutants have altered chromatin accessibility at silenced loci like HML, with less efficient formation of mono- and di-nucleosomes upon digestion compared to wildtype cells .

  • Combinatorial Effects: Combined mutations affecting both H3K4 and H3K79 (H3K4,79R) show greater UV sensitivity than either single mutation, suggesting that these modifications may have complementary roles in the DNA damage response .

A proposed mechanism involves H3K79 methylation creating a more "flexible" chromatin structure that allows repair machinery to access DNA lesions, particularly in heterochromatic regions.

How does H3K79 methylation influence chromatin structure and gene expression?

H3K79 methylation impacts chromatin organization and gene expression through several mechanisms:

  • Heterochromatin Regulation: Approximately 90% of the yeast genome is hypermethylated at H3K79, while the remaining 10% (primarily heterochromatin) is hypomethylated. This pattern helps establish and maintain heterochromatic domains .

  • Sir Protein Recruitment: Sir proteins (Silent Information Regulators) preferentially bind to nucleosomes with hypomethylated H3K79. In H3K79R mutants, which mimic the hypomethylated state, increased Sir2 recruitment to silenced loci like HML has been observed, enhancing transcriptional silencing .

  • Chromatin Compaction: H3K79 methylation affects higher-order chromatin structure. H3K79R mutations lead to more compact, less accessible chromatin at silenced loci, as demonstrated by reduced MNase sensitivity .

  • Transcriptional Outcomes: The relationship between H3K79 methylation and transcription is context-dependent:

    • In euchromatin, H3K79 methylation generally correlates with active transcription

    • In heterochromatin, loss of H3K79 methylation enhances silencing through increased Sir protein binding

These findings highlight how H3K79 methylation serves as an epigenetic switch that influences chromatin states and consequently affects both gene expression and DNA repair processes.

What are the recommended protocols for using Tri-Methyl-Histone H3 (Lys79) Antibody in ChIP experiments?

For optimal ChIP results with Tri-Methyl-Histone H3 (Lys79) antibodies, the following protocol recommendations should be considered:

Recommended ChIP Protocol:

  • Sample Preparation:

    • Use fresh or frozen cell/tissue samples (4-10 × 10^6 cells per IP)

    • Crosslink with 1% formaldehyde for 10 minutes at room temperature

    • Quench with 125 mM glycine for 5 minutes

  • Chromatin Preparation:

    • Lyse cells and isolate nuclei

    • Sonicate to generate DNA fragments of 200-500 bp

    • Verify fragmentation by agarose gel electrophoresis

  • Immunoprecipitation:

    • Use 10 μg of chromatin and 10 μl of antibody per IP for optimal results

    • Include appropriate controls (IgG, input, positive control antibody)

    • Incubate overnight at 4°C with rotation

  • Washing and Elution:

    • Use stringent washing conditions to reduce background

    • Elute chromatin-antibody complexes

    • Reverse crosslinking (65°C overnight)

    • Treat with RNase A and Proteinase K

  • DNA Purification and Analysis:

    • Purify DNA using column-based methods

    • Analyze by qPCR, sequencing, or other downstream applications

Optimization Tips:

  • The antibody dilution for ChIP applications is typically 1:50

  • For ChIP-seq, ensure high antibody specificity to avoid false positives

  • Consider using enzymatic fragmentation (e.g., SimpleChIP® Enzymatic Chromatin IP Kits) as an alternative to sonication

  • Validate enrichment at known targets before proceeding to genome-wide analyses

How can researchers troubleshoot cross-reactivity issues with Tri-Methyl-Histone H3 (Lys79) Antibody?

When encountering potential cross-reactivity issues with Tri-Methyl-Histone H3 (Lys79) antibodies, implement this systematic troubleshooting approach:

  • Characterize Cross-Reactivity Profile:

    • Perform peptide array analysis against a comprehensive panel of histone modifications

    • Calculate specificity factors for H3K79me3 versus other methylation states (H3K79me1, H3K79me2)

    • Test cross-reactivity with other trimethylated lysines (e.g., H3K4me3, H3K9me3, H3K27me3, H3K36me3)

  • Implement Blocking Strategies:

    • Pre-incubate antibody with excess non-target peptides that show cross-reactivity

    • Optimize antibody concentration to minimize non-specific binding while maintaining specific signal

    • Consider dual-antibody approaches where confirmation with a second antibody validates findings

  • Genetic Controls:

    • Use DOT1/DOT1L knockout or catalytically-inactive mutants to generate samples lacking H3K79me3

    • Employ H3K79R mutant cells as negative controls

    • Create spike-in controls with known H3K79me3 levels for quantitative normalization

  • Sequential ChIP Approach:

    • Perform tandem immunoprecipitations with antibodies targeting different epitopes

    • First, precipitate with a broader histone H3 antibody, then with the H3K79me3-specific antibody

    • Alternatively, use antibodies against co-occurring modifications to refine target population

  • Data Analysis Strategies:

    • Implement computational approaches to distinguish true signal from cross-reactivity

    • Compare signal distributions to expected genomic patterns of H3K79me3

    • Develop normalization methods based on well-characterized control regions

By combining these methodological approaches, researchers can significantly reduce the impact of antibody cross-reactivity and improve the reliability of H3K79me3 detection in complex experimental systems.

What methodological approaches can resolve contradictions in the literature regarding H3K79 methylation patterns?

Contradictions in the literature regarding H3K79 methylation patterns can be resolved through systematic methodological approaches:

  • Standardized Chromatin Preparation:

    • Develop consensus protocols for crosslinking, sonication, and immunoprecipitation

    • Compare native ChIP versus crosslinked ChIP results to identify technical artifacts

    • Standardize cell synchronization methods when studying cell-cycle dependent patterns

  • Antibody Benchmarking:

    • Create a reference panel of H3K79 antibodies validated by multiple methods

    • Directly compare antibody performance using identical samples and protocols

    • Establish minimum validation criteria for antibodies used in published studies

  • Genetic Engineering Approaches:

    • Generate isogenic cell lines with targeted mutations in H3K79 or DOT1/DOT1L

    • Use CRISPR-Cas9 to create endogenously tagged histones for direct detection

    • Develop systems with inducible expression of mutant histones to study dynamics

  • Multi-Omics Integration:

    • Combine ChIP-seq data with RNA-seq, ATAC-seq, and MNase-seq from the same samples

    • Use multiple orthogonal techniques to validate chromatin states (e.g., DamID, CUT&RUN)

    • Apply single-cell approaches to resolve cell population heterogeneity

  • Context-Specific Analysis:

    • Evaluate H3K79 methylation in specific genomic contexts (heterochromatin vs. euchromatin)

    • Account for nuclear compartmentalization and higher-order chromatin organization

    • Consider organism-specific differences in H3K79 methylation patterns and functions

The application of these methodological frameworks allows researchers to systematically address contradictions and develop more consistent models of H3K79 methylation patterns and functions across different cellular contexts.

How does the mechanism of H3K79 methylation differ from H4K20 methylation?

The mechanisms of H3K79 and H4K20 methylation exhibit distinct enzymatic pathways, structural contexts, and functional outcomes:

Enzymatic Regulation:

AspectH3K79 MethylationH4K20 Methylation
Primary MethyltransferasesDOT1/DOT1L (sole enzyme)SETD8 (mono-), SUV4-20H1 & SUV4-20H2 (di-/tri-)
DemethylasesNo known specific demethylasesKDM5A and potentially others
Catalytic MechanismNon-SET domain methyltransferaseSET domain-containing methyltransferases
Sequential MethylationDOT1/DOT1L can catalyze mono-, di-, and tri-methylationSETD8 catalyzes mono-methylation; SUV4-20 enzymes catalyze di- and tri-methylation

Structural Context:

  • Location: H3K79 is located within the globular domain of histone H3, whereas H4K20 is located on the N-terminal tail of histone H4 .

  • Nucleosome Surface Interactions: H3K79 is part of a nucleosome surface formed by interactions with H2A (particularly residues L116 and L117) and H4K44 . H4K20 is more accessible on the histone tail.

  • Reader Proteins: Different reader protein domains recognize these modifications:

    • H3K79me3: Recognized by specific tudor domain proteins

    • H4K20me3: Recognized by chromo, tudor, MBT, WD40, and other methyl-lysine binding domains

Functional Differences:

  • Genomic Distribution:

    • H3K79me3: Predominantly found in euchromatic regions, with approximately 90% of the yeast genome hypermethylated

    • H4K20me3: Enriched at heterochromatic regions, particularly at repetitive elements and silenced genes

  • Biological Roles:

    • H3K79me3: Critical for DNA repair (particularly NER), transcriptional regulation, and preventing abnormal silencing

    • H4K20me3: Essential for chromatin structure, cell cycle regulation, DNA repair (particularly double-strand break repair), and development

  • Cell Cycle Dynamics:

    • H3K79 methylation is relatively stable throughout the cell cycle

    • H4K20 methylation shows pronounced cell cycle dependence, with H4K20me1 peaking during G2/M and H4K20me3 accumulating in differentiated cells

Understanding these mechanistic differences is essential for designing experiments that appropriately investigate the distinct roles of these modifications in chromatin regulation and cellular function.

What experimental strategies can quantitatively assess the relationship between H3K79 methylation and DNA repair efficiency?

To quantitatively assess the relationship between H3K79 methylation and DNA repair efficiency, researchers can implement these advanced experimental strategies:

  • Locus-Specific Repair Assays:

    • UV-Induced Damage and Repair:

      • Induce DNA damage with controlled UV doses

      • Measure CPD (cyclobutane pyrimidine dimer) removal rates using T4 endonuclease V digestion and Southern blotting

      • Compare repair rates between wildtype, H3K79R mutants, and DOT1/DOT1L knockout cells

      • Analyze repair efficiency at specific genomic loci (e.g., transcriptionally active vs. silenced regions)

  • Genome-Wide Repair Mapping:

    • Damage-Seq/XR-Seq: Map the genome-wide distribution of DNA damage and repair

    • ChIP-seq for Repair Factors: Analyze recruitment of NER factors (XPC, TFIIH, XPA) in relation to H3K79me3 distribution

    • ERATO-seq: Map excision repair at nucleotide resolution and correlate with histone modification patterns

  • Chromatin Accessibility Analysis:

    • MNase-seq: Compare nucleosome positioning and stability between wildtype and H3K79 methylation-deficient cells

    • ATAC-seq: Assess chromatin accessibility genome-wide

    • Correlation Analysis: Quantify relationships between H3K79me3 levels, chromatin accessibility, and repair rates

  • Live-Cell Repair Dynamics:

    • FRAP (Fluorescence Recovery After Photobleaching): Measure mobility of repair factors in H3K79 methylation-deficient backgrounds

    • Microirradiation Studies: Track recruitment kinetics of repair proteins to damaged sites

    • Real-time Single-Molecule Tracking: Monitor repair complex assembly in relation to H3K79 methylation status

  • Quantitative Biochemical Approaches:

    • In Vitro Repair Assays: Reconstitute repair reactions with nucleosomes containing or lacking H3K79me3

    • Crosslinking-Mass Spectrometry: Identify direct interactions between repair factors and modified histones

    • Nucleosome Stability Measurements: Quantify how H3K79 methylation affects nucleosome dynamics during repair

Experimental data from multiple approaches can be integrated through mathematical modeling to develop quantitative frameworks that explain how H3K79 methylation influences repair efficiency in different chromatin contexts.

How can researchers design experiments to investigate the interplay between H3K79 methylation and other histone modifications?

Designing experiments to investigate the interplay between H3K79 methylation and other histone modifications requires sophisticated approaches that can detect complex regulatory relationships:

  • Sequential and Combinatorial ChIP Approaches:

    • Sequential ChIP (Re-ChIP): Perform tandem immunoprecipitations to identify co-occurrence of H3K79me3 with other modifications

    • Barcode-ChIP: Use DNA barcoding strategies to multiplex ChIP experiments for multiple modifications

    • Mass Spectrometry-Based Methods: Analyze co-occurring modifications on the same histone molecules

  • Genetic Manipulation Strategies:

    • Histone Mutant Arrays: Generate comprehensive libraries of histone mutants affecting H3K79 and interacting modifications

    • Methyltransferase/Demethylase Perturbation: Create cell lines with inducible expression or degradation of relevant enzymes

    • Combinatorial CRISPR Screens: Target multiple histone-modifying enzymes to identify synthetic interactions

  • Spatial Organization Analysis:

    • Super-Resolution Microscopy: Map the 3D nuclear distribution of H3K79me3 in relation to other modifications

    • Proximity Ligation Assays: Detect co-localization of different histone marks at the single-molecule level

    • Hi-C Integration: Correlate 3D chromatin organization with histone modification patterns

  • Temporal Dynamics Investigation:

    • SNAP-ChIP: Use spike-in nucleosomes with defined modifications to quantify absolute levels and turnover rates

    • Pulse-Chase Experiments: Track the establishment and removal of modifications after perturbation

    • Single-Cell Temporal Analysis: Monitor modification patterns through cell cycle or differentiation

  • Functional Readout Assays:

    • CRISPR Activation/Repression: Target specific genomic regions to manipulate H3K79me3 levels locally

    • Nucleosome Dynamics Reporters: Deploy real-time reporters of chromatin state and transcriptional activity

    • Epistasis Analysis: Determine hierarchical relationships between different histone modifications

Implementing these experimental designs with appropriate controls and quantitative analyses will provide mechanistic insights into how H3K79 methylation functionally interacts with other histone modifications to regulate chromatin structure and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.